Wasquehal, France

Jean-Paul Bonte


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Journey of Jean-Paul Bonte

Introduction

Jean-Paul Bonte is an accomplished inventor based in Wasquehal, France. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on heterocyclic aminomethyl compounds. His research and inventions have far-reaching implications in the development of medicinal products.

Latest Patents

Jean-Paul holds a patent for "Heterocyclic aminomethyl compounds," identified by a general formula that includes specific definitions for A, X, R1, Y, n, and Ar within the detailed description. This groundbreaking compound shows promise as a D4 receptor ligand, indicating its potential use in therapeutic applications.

Career Highlights

Currently, Jean-Paul works for Adir et Compagnie, a company focused on advancing innovations in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the exploration of novel medicinal compounds. With one patented invention to his name, Jean-Paul continuously seeks to learn and innovate within his field.

Collaborations

Throughout his career, Jean-Paul has collaborated with esteemed colleagues such as Daniel Lesieur and Pascal Carato. These partnerships have enhanced his research endeavors and contributed to the overall advancement of knowledge within medicinal chemistry.

Conclusion

In summary, Jean-Paul Bonte represents the spirit of innovation in the realm of medicinal products. His patent on heterocyclic aminomethyl compounds opens new doors for therapeutic possibilities. Through his work at Adir et Compagnie and his collaboration with notable peers, he continues to inspire the next generation of inventors and researchers in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…